{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T14:09:53Z","timestamp":1783951793985,"version":"3.55.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,9]],"date-time":"2024-04-09T00:00:00Z","timestamp":1712620800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Nederlandse Hartstichting","doi-asserted-by":"publisher","award":["NHS 2010B167"],"award-info":[{"award-number":["NHS 2010B167"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012028","name":"Trombosestichting Nederland","doi-asserted-by":"publisher","award":["2022"],"award-info":[{"award-number":["2022"]}],"id":[{"id":"10.13039\/501100012028","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jthjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Thrombosis and Haemostasis"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/j.jtha.2024.03.014","type":"journal-article","created":{"date-parts":[[2024,3,28]],"date-time":"2024-03-28T18:54:17Z","timestamp":1711652057000},"page":"2195-2202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women"],"prefix":"10.1016","volume":"22","author":[{"given":"Judith P.L.","family":"Verlaan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernadine H.","family":"Stegeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmijn F.","family":"Timp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luuk J.J.","family":"Scheres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda E.","family":"Flinterman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frans M.","family":"Helmerhorst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits R.","family":"Rosendaal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne C.","family":"Cannegieter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"van Hylckama Vlieg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jtha.2024.03.014_bib1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1016\/S0140-6736(95)91926-0","article-title":"Venous thromboembolic disease and combined oral contraceptives: results of international multicentre case-control study. World Health Organization collaborative study of cardiovascular disease and steroid hormone contraception","volume":"346","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/j.jtha.2024.03.014_bib2","doi-asserted-by":"crossref","first-page":"4693","DOI":"10.1182\/bloodadvances.2020001830","article-title":"American Society of Hematology 2020 guidelines for management of venous thromboembolism: treatment of deep vein thrombosis and pulmonary embolism","volume":"4","author":"Ortel","year":"2020","journal-title":"Blood Adv"},{"key":"10.1016\/j.jtha.2024.03.014_bib3","doi-asserted-by":"crossref","first-page":"e545","DOI":"10.1016\/j.chest.2021.07.055","article-title":"Antithrombotic therapy for VTE disease: second update of the CHEST Guideline and Expert Panel Report","volume":"160","author":"Stevens","year":"2021","journal-title":"Chest"},{"key":"10.1016\/j.jtha.2024.03.014_bib4","doi-asserted-by":"crossref","first-page":"2352","DOI":"10.1001\/jama.293.19.2352","article-title":"Thrombophilia, clinical factors, and recurrent venous thrombotic events","volume":"293","author":"Christiansen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.03.014_bib5","first-page":"56","article-title":"Hormonal contraceptive use after venous thrombosis: practice from 1999 to 2004","volume":"4","author":"Stegeman","year":"2014","journal-title":"J\u00a0Endocrinol Metab"},{"key":"10.1016\/j.jtha.2024.03.014_bib6","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1111\/jth.15661","article-title":"Risk of recurrence in women with venous thromboembolism related to estrogen-containing contraceptives: systematic review and meta-analysis","volume":"20","author":"Wiegers","year":"2022","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.014_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/bjh.18331","article-title":"Recurrence after stopping anticoagulants in women with combined oral contraceptive-associated venous thromboembolism: a systematic review and meta-analysis","volume":"19","author":"Abdulrehman","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/j.jtha.2024.03.014_bib8","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1111\/j.1538-7836.2012.04662.x","article-title":"Duration of anticoagulant therapy after a first episode of an unprovoked pulmonary embolus or deep vein thrombosis: guidance from the SSC of the ISTH","volume":"10","author":"Baglin","year":"2012","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.014_bib9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1182\/blood-2015-08-665927","article-title":"Recurrent venous thromboembolism and abnormal uterine bleeding with anticoagulant and hormone therapy use","volume":"127","author":"Martinelli","year":"2016","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.014_bib10","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1001\/jama.293.6.715","article-title":"Malignancies, prothrombotic mutations, and the risk of venous thrombosis","volume":"293","author":"Blom","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/j.jtha.2024.03.014_bib11","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1111\/jth.13113","article-title":"Predictive value of factor VIII levels for recurrent venous thrombosis: results from the MEGA follow-up study","volume":"13","author":"Timp","year":"2015","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.014_bib12","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1111\/jth.14549","article-title":"Sex matters: practice 5P\u2019s when treating young women with venous thromboembolism","volume":"17","author":"Bistervels","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.014_bib13","doi-asserted-by":"crossref","first-page":"2603","DOI":"10.1182\/blood-2017-07-797423","article-title":"How I treat heavy menstrual bleeding associated with anticoagulants","volume":"130","author":"Boonyawat","year":"2017","journal-title":"Blood"},{"key":"10.1016\/j.jtha.2024.03.014_bib14","author":"Wickham","year":"2023","journal-title":"Package \u2018dplyr.\u2019 A grammar of data manipulation, version 1.1.2"},{"key":"10.1016\/j.jtha.2024.03.014_bib15","author":"Therneau","year":"2022","journal-title":"Package \u2018survival.\u2019 A package for survival analysis in R, version 3.3-1"},{"key":"10.1016\/j.jtha.2024.03.014_bib16","author":"Gordon","year":"2022","journal-title":"Package \u2018forestplot.\u2019 Advanced forest plot using 'grid' graphics, version 3.1.1"},{"key":"10.1016\/j.jtha.2024.03.014_bib17","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1111\/jth.12528","article-title":"The risk of recurrence in women with venous thromboembolism while using estrogens: a prospective cohort study","volume":"12","author":"Eischer","year":"2014","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.014_bib18","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/j.1538-7836.2010.03994.x","article-title":"Sex difference in risk of recurrent venous thrombosis and the risk profile for a second event","volume":"8","author":"Christiansen","year":"2010","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.014_bib19","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1515\/cclm-2023-0384","article-title":"The effect of hormonal contraceptive therapy on clinical laboratory parameters: a literature review","volume":"62","author":"\u00d6zcan","year":"2024","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/j.jtha.2024.03.014_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.769187","article-title":"Combined oral contraceptives and venous thromboembolism: review and perspective to mitigate the risk","volume":"12","author":"Morimont","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/j.jtha.2024.03.014_bib21","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.contraception.2016.06.010","article-title":"Impact of estrogen type on cardiovascular safety of combined oral contraceptives","volume":"94","author":"Dinger","year":"2016","journal-title":"Contraception"},{"key":"10.1016\/j.jtha.2024.03.014_bib22","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1111\/aogs.14384","article-title":"Systemic hormonal contraception and risk of venous thromboembolism","volume":"101","author":"Heikinheimo","year":"2022","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.jtha.2024.03.014_bib23","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/j.contraception.2020.08.015","article-title":"Evaluation of the effect of a new oral contraceptive containing estetrol and drospirenone on hemostasis parameters","volume":"102","author":"Douxfils","year":"2020","journal-title":"Contraception"},{"key":"10.1016\/j.jtha.2024.03.014_bib24","doi-asserted-by":"crossref","first-page":"l4363","DOI":"10.1136\/bmj.l4363","article-title":"Long term risk of symptomatic recurrent venous thromboembolism after discontinuation of anticoagulant treatment for first unprovoked venous thromboembolism event: systematic review and meta-analysis","volume":"366","author":"Khan","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/j.jtha.2024.03.014_bib25","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1111\/jth.14534","article-title":"Predicting the risk of recurrent venous thrombosis: what the future might bring","volume":"17","author":"Lijfering","year":"2019","journal-title":"J\u00a0Thromb Haemost"},{"key":"10.1016\/j.jtha.2024.03.014_bib26","doi-asserted-by":"crossref","first-page":"5595","DOI":"10.1182\/bloodadvances.2020002268","article-title":"Which patients are at high risk of recurrent venous thromboembolism (deep vein thrombosis and pulmonary embolism)?","volume":"4","author":"\u00c1inle","year":"2020","journal-title":"Blood Adv"}],"container-title":["Journal of Thrombosis and Haemostasis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624001727?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1538783624001727?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T02:05:20Z","timestamp":1721700320000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1538783624001727"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S1538783624001727"],"URL":"https:\/\/doi.org\/10.1016\/j.jtha.2024.03.014","relation":{},"ISSN":["1538-7836"],"issn-type":[{"value":"1538-7836","type":"print"}],"subject":[],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hormonal contraceptive use after a first venous thrombotic event and the risk of recurrence in premenopausal women","name":"articletitle","label":"Article Title"},{"value":"Journal of Thrombosis and Haemostasis","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jtha.2024.03.014","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Authors. Published by Elsevier Inc. on behalf of International Society on Thrombosis and Haemostasis.","name":"copyright","label":"Copyright"}]}}